CALR mutation burden in essential thrombocythemia and disease outcome

Paola Guglielmelli1, Natasha Szuber2,3,4, Naseema Gangat5

  • 1Department of Experimental and Clinical Medicine, Center of Research and Innovation of Myeloproliferative Neoplasms, Division of Hematology, Azienda Ospedaliera Universitaria Careggi, Florence, Italy.

Blood
|January 22, 2024
PubMed